🇺🇸 Low-dose heparin in United States
3 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 3
Most-reported reactions
- Hepatorenal Syndrome — 1 report (33.33%)
- Product Use In Unapproved Indication — 1 report (33.33%)
- Venoocclusive Disease — 1 report (33.33%)
Other Cardiovascular approved in United States
Frequently asked questions
Is Low-dose heparin approved in United States?
Low-dose heparin does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Low-dose heparin in United States?
San Filippo Neri General Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.